Skip to content
value.today

Quantrx Biomedical Corp.

Formerly A Fem Medical Corporation, Athena Medical Corporation

Total raised
$406 M
1 round on record
Latest round
$406 M
Jul 2009
First round on record
Jul 2009
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Quantrx Biomedical Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2009$406 MNo. 1$250 million to $1 billion

Quantrx Biomedical Corp.: Raise no. 1, Jul 2009

Investors in this round

13 investors had bought by the notice of Aug 14, 2009: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$406 M of $406 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Sasha Afanassiev · Executive Officer
  • William H. Fleming · Director, Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sasha Afanassiev, Treasurer. Source: SEC Form D, newest notice filed Aug 14, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Quantrx Biomedical Corp. had revenue of up to $1 million when it filed its newest notice of a funding round (Aug 2009).

    SEC Form D (revenue range) · Aug 2009

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2009

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Quantrx Biomedical Corp. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 13 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Quantrx Biomedical Corp.
NameRoleNamed in
Sasha AfanassievExecutive officerAug 2009
William H. FlemingExecutive officerAug 2009
William H. FlemingDirectorAug 2009